• Je něco špatně v tomto záznamu ?

Highly effective Ru(II) and Os(II) half-sandwich complexes induce cytotoxicity in cancer cells through combined mitochondrial and endoplasmic reticulum stress

J. Hošek, K. Petrželová, R. Héžová, N. Straková, S. Kajabová, I. Nemec, P. Šimečková, K. Pěnčíková, J. Mašek, J. Moncoľ, P. Štarha

. 2025 ; 297 (-) : 117970. [pub] 20250711

Jazyk angličtina Země Francie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25021372

A series of ruthenium(II) and osmium(II) half-sandwich complexes was synthesized and characterized for its potential as a new class of anticancer agents. The complexes feature polycyclic aromatic hydrocarbon (PAH)-substituted Schiff bases and were rationally designed to combine the redox-modulating MoA of half-sandwich Ru, Rh, Os and Ir complexes, connected with their ability to induce the formation of various reactive oxygen species (ROS), with the ability of PAH-substituents to target and disrupt DNA. The complexes [Ru(η6-pcym)Cl(L)]PF6 (1-4) and [Os(η6-pcym)Cl(L)]PF6 (5-8) were stable in aqueous environments, in contrast to the rapid degradation observed for the co-studied rhodium(III) (9-12) and iridium(III) (13-16) [M(η5-Cp∗)Cl(L)]PF6 complexes; L = ethane-1,2-diamine-based Schiff bases (L1-L4) bearing two terminal PAH substituents 2-naphtyl (for L1), 9-anthracenyl (for L2), 9-phenanthrenyl (L3) or 1-pyrenyl (L4); pcym = 1-methyl-4-(propan-2-yl)benzene (p-cymene), Cp∗ = pentamethylcyclopentadienyl. Biological testing demonstrated that 1-8 possess significant antiproliferative activity against various lung cancer cell lines, including those resistant to cisplatin, with Os(II) complex 5 showing the highest cytotoxicity. Treatment with these complexes led to the activation of stress-related gene pathways, including unconventional endoplasmic reticulum stress, apoptotic signalling, and mitochondrial membrane depolarization. Activation of p21/GADD45A pathway indicates DNA-damage response, as well. Notably, these complexes did not induce significant inflammatory responses, a notable advantage over cisplatin. The results highlight the potential of Ru and Os half-sandwich complexes as alternative metallodrugs, capable of overcoming platinum resistance and minimizing inflammatory side effects. This study suggests that these compounds could serve as a promising class of anticancer agents for future clinical development.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25021372
003      
CZ-PrNML
005      
20251023075616.0
007      
ta
008      
251014e20250711fr f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejmech.2025.117970 $2 doi
035    __
$a (PubMed)40701010
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a fr
100    1_
$a Hošek, Jan $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, Brno, 62100, Czech Republic. Electronic address: jan.hosek@vri.cz
245    10
$a Highly effective Ru(II) and Os(II) half-sandwich complexes induce cytotoxicity in cancer cells through combined mitochondrial and endoplasmic reticulum stress / $c J. Hošek, K. Petrželová, R. Héžová, N. Straková, S. Kajabová, I. Nemec, P. Šimečková, K. Pěnčíková, J. Mašek, J. Moncoľ, P. Štarha
520    9_
$a A series of ruthenium(II) and osmium(II) half-sandwich complexes was synthesized and characterized for its potential as a new class of anticancer agents. The complexes feature polycyclic aromatic hydrocarbon (PAH)-substituted Schiff bases and were rationally designed to combine the redox-modulating MoA of half-sandwich Ru, Rh, Os and Ir complexes, connected with their ability to induce the formation of various reactive oxygen species (ROS), with the ability of PAH-substituents to target and disrupt DNA. The complexes [Ru(η6-pcym)Cl(L)]PF6 (1-4) and [Os(η6-pcym)Cl(L)]PF6 (5-8) were stable in aqueous environments, in contrast to the rapid degradation observed for the co-studied rhodium(III) (9-12) and iridium(III) (13-16) [M(η5-Cp∗)Cl(L)]PF6 complexes; L = ethane-1,2-diamine-based Schiff bases (L1-L4) bearing two terminal PAH substituents 2-naphtyl (for L1), 9-anthracenyl (for L2), 9-phenanthrenyl (L3) or 1-pyrenyl (L4); pcym = 1-methyl-4-(propan-2-yl)benzene (p-cymene), Cp∗ = pentamethylcyclopentadienyl. Biological testing demonstrated that 1-8 possess significant antiproliferative activity against various lung cancer cell lines, including those resistant to cisplatin, with Os(II) complex 5 showing the highest cytotoxicity. Treatment with these complexes led to the activation of stress-related gene pathways, including unconventional endoplasmic reticulum stress, apoptotic signalling, and mitochondrial membrane depolarization. Activation of p21/GADD45A pathway indicates DNA-damage response, as well. Notably, these complexes did not induce significant inflammatory responses, a notable advantage over cisplatin. The results highlight the potential of Ru and Os half-sandwich complexes as alternative metallodrugs, capable of overcoming platinum resistance and minimizing inflammatory side effects. This study suggests that these compounds could serve as a promising class of anticancer agents for future clinical development.
650    _2
$a lidé $7 D006801
650    12
$a ruthenium $x chemie $x farmakologie $7 D012428
650    12
$a protinádorové látky $x farmakologie $x chemie $x chemická syntéza $7 D000970
650    12
$a osmium $x chemie $x farmakologie $7 D009992
650    12
$a stres endoplazmatického retikula $x účinky léků $7 D059865
650    12
$a mitochondrie $x účinky léků $x metabolismus $7 D008928
650    _2
$a screeningové testy protinádorových léčiv $7 D004354
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a molekulární struktura $7 D015394
650    12
$a komplexní sloučeniny $x farmakologie $x chemie $x chemická syntéza $7 D056831
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a reaktivní formy kyslíku $x metabolismus $7 D017382
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    12
$a organokovové sloučeniny $x farmakologie $x chemie $x chemická syntéza $7 D009942
655    _2
$a časopisecké články $7 D016428
700    1_
$a Petrželová, Kamila $u Department of Inorganic Chemistry, Faculty of Science, Palacky University Olomouc, 17. listopadu 12, 77146, Olomouc, Czech Republic
700    1_
$a Héžová, Renata $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, Brno, 62100, Czech Republic
700    1_
$a Straková, Nicol $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, Brno, 62100, Czech Republic
700    1_
$a Kajabová, Simona $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, Brno, 62100, Czech Republic
700    1_
$a Nemec, Ivan $u Department of Inorganic Chemistry, Faculty of Science, Palacky University Olomouc, 17. listopadu 12, 77146, Olomouc, Czech Republic
700    1_
$a Šimečková, Pavlína $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, Brno, 62100, Czech Republic
700    1_
$a Pěnčíková, Kateřina $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, Brno, 62100, Czech Republic
700    1_
$a Mašek, Josef $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, Brno, 62100, Czech Republic
700    1_
$a Moncoľ, Ján $u Department of Inorganic Chemistry, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Bratislava, SK-81237, Slovakia
700    1_
$a Štarha, Pavel $u Department of Inorganic Chemistry, Faculty of Science, Palacky University Olomouc, 17. listopadu 12, 77146, Olomouc, Czech Republic. Electronic address: pavel.starha@upol.cz
773    0_
$w MED00001628 $t European journal of medicinal chemistry $x 1768-3254 $g Roč. 297 (20250711), s. 117970
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40701010 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20251014 $b ABA008
991    __
$a 20251023075622 $b ABA008
999    __
$a ok $b bmc $g 2416668 $s 1259535
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 297 $c - $d 117970 $e 20250711 $i 1768-3254 $m European journal of medicinal chemistry $n Eur J Med Chem $x MED00001628
LZP    __
$a Pubmed-20251014

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...